Heart Rate Control as an Additional Therapeutic Strategy in Patients With Decompensated Heart Failure: a Prospective, Randomized, Double-blinded, Placebo-controlled Study. (CONSTATHE)

NCT02236247 Phase 1/Phase 2 UNKNOWN

Study aims to compare the I(f) inhibitor ivabradine with placebo as strategy of heart rate control in patients with decompensated heart failure (DHF).

Details

Lead sponsor	University of Sao Paulo
Phase	Phase 1/Phase 2
Status	UNKNOWN
Enrolment	50
Start date	2013-05
Completion	2017-08

Conditions

• Decompensated Heart Failure

Interventions

• ivabradine
• Placebo

Primary outcomes

• Change from baseline heart rate — Baseline, day 5 after intervention
  Heart rate will be assessed at morning, after 30 minutes of rest, recorded by electrocardiogram.

Countries

Brazil